SK18822001A3 - Terapeutické činidlá - Google Patents

Terapeutické činidlá Download PDF

Info

Publication number
SK18822001A3
SK18822001A3 SK1882-2001A SK18822001A SK18822001A3 SK 18822001 A3 SK18822001 A3 SK 18822001A3 SK 18822001 A SK18822001 A SK 18822001A SK 18822001 A3 SK18822001 A3 SK 18822001A3
Authority
SK
Slovakia
Prior art keywords
formula
compound
methyl
lipase inhibitor
group
Prior art date
Application number
SK1882-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Alan Martin Birch
David John Heal
Original Assignee
Knoll Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Aktiengesellschaft filed Critical Knoll Aktiengesellschaft
Publication of SK18822001A3 publication Critical patent/SK18822001A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1882-2001A 1999-06-24 2000-06-16 Terapeutické činidlá SK18822001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9914742.3A GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
PCT/EP2000/005544 WO2001000187A2 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor

Publications (1)

Publication Number Publication Date
SK18822001A3 true SK18822001A3 (sk) 2003-04-01

Family

ID=10855953

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1882-2001A SK18822001A3 (sk) 1999-06-24 2000-06-16 Terapeutické činidlá

Country Status (20)

Country Link
EP (1) EP1189638A2 (pt)
JP (1) JP2003503344A (pt)
KR (1) KR20020012293A (pt)
CN (1) CN1365287A (pt)
AU (1) AU5815100A (pt)
BG (1) BG106209A (pt)
BR (1) BR0011884A (pt)
CA (1) CA2376213A1 (pt)
CZ (1) CZ20014614A3 (pt)
GB (1) GB9914742D0 (pt)
HK (1) HK1050476A1 (pt)
HU (1) HUP0201880A3 (pt)
IL (1) IL147078A0 (pt)
MX (1) MXPA01013023A (pt)
NO (1) NO20016301D0 (pt)
PL (1) PL352387A1 (pt)
SK (1) SK18822001A3 (pt)
TR (1) TR200103704T2 (pt)
WO (1) WO2001000187A2 (pt)
ZA (1) ZA200110046B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US7089666B2 (en) * 2003-06-06 2006-08-15 The Regents Of The University Of California Microfabricated vertical comb actuator using plastic deformation
JP2010503709A (ja) 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ,インコーポレーテッド シクロアルキルメチルアミンの合成、使用方法および組成物
CN101890017A (zh) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 含有西布曲明和他汀类降脂药物的药物组合物及其用途
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
US9238625B2 (en) 2011-12-30 2016-01-19 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

Also Published As

Publication number Publication date
CA2376213A1 (en) 2001-01-04
AU5815100A (en) 2001-01-31
CZ20014614A3 (cs) 2004-02-18
GB9914742D0 (en) 1999-08-25
PL352387A1 (en) 2003-08-25
JP2003503344A (ja) 2003-01-28
BG106209A (en) 2002-09-30
CN1365287A (zh) 2002-08-21
ZA200110046B (en) 2003-03-06
HUP0201880A3 (en) 2003-03-28
KR20020012293A (ko) 2002-02-15
NO20016301L (no) 2001-12-21
NO20016301D0 (no) 2001-12-21
TR200103704T2 (tr) 2002-05-21
EP1189638A2 (en) 2002-03-27
HK1050476A1 (zh) 2003-06-27
BR0011884A (pt) 2003-08-12
HUP0201880A2 (hu) 2002-12-28
WO2001000187A3 (en) 2001-11-15
MXPA01013023A (es) 2003-08-01
IL147078A0 (en) 2002-08-14
WO2001000187A2 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
US20030130355A1 (en) Therapeutic agents
RU2197959C2 (ru) Применение аналогов сибутрамина для снижения уровней липидов
EP1039900B1 (en) Pharmaceutical composition containing sibutramine and orlistat
JP2001501608A (ja) 医学的処理
US6376552B1 (en) Treatment of gallstones
SK18242001A3 (sk) Terapeutické prípravky na báze sibutramínu vrátane jeho enantiomérov a farmaceuticky prijateľných solí a orlistatu a ich použitie
SK18822001A3 (sk) Terapeutické činidlá
US6232347B1 (en) Treatment of osteoarthritis
AU773490B2 (en) Treatment of osteoarthritis
US6403650B1 (en) Treatment of pulmonary hypertension
US20040198837A1 (en) Treatment of neuropathic pain or fibromyalgia
RU2234917C2 (ru) Терапевтические средства
MXPA00006201A (en) Pharmaceutical composition containing sibutramine and orlistat
WO2000056316A1 (en) Treatment of gallstones